Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

Requests that the FDA include additional warnings that should be added to prescribing information on Hormonally-active contraceptives (HCs) and the development of autoimmune diseases

🏛 Food and Drug Administration (FDA)FDA-2026-P-3869
Pharmaceutical Policy
Documents
10
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 10Supporting & Related Material 9Other 1
📄 Primary document
Supporting & Related MaterialApr 15, 2026
Brennan and Klaus 1982
Open →